M3, the healthcare services provider, has expanded its global operations with the acquisition of healthcare informatics firm Vidal Group. In a move to complement its existing business activities across the UK, US and Asia, M3 is now set to support the growth of Vidal's services focusing on key markets in Europe and Latin America. Vidal Group currently specialises in providing reference drug information for healthcare professionals, with online databases tailored to cover all the latest treatment information and medical advances. Now part of the M3 network - which includes M3.com, MDLinx, Medigate, medlive.cn, M3Medical and Doctors.net.uk - the group will also offer market research, digital communications and clinical trials and recruitment services. Aki Tomaru, board director and chief executive of M3 USA, said:
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!